| View |
|
DRP-6523-03
|
Ivabradine (as hydrochloride)
|
Gavrila
|
7.5mg
|
Film-Coated Tablet
|
Anti-Angina
|
Bafna Pharmaceuticals Ltd.
|
India
|
CLIDP Conversion
|
29 September 2024
|
03 February 2026
|
| View |
|
DRP-8409-01
|
Folic Acid
|
None
|
5 mg
|
Capsule
|
Hematinic
|
Drugmaker's Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
15 September 2024
|
28 November 2028
|
| View |
|
DRP-8403-12
|
Cefuroxime (as Sodium)
|
Cefulab
|
750 mg
|
Powder for Injection (IM/IV)
|
Antibacterial (Second Generation Cephalosporin)
|
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
|
China
|
CLIDP Conversion
|
24 September 2024
|
15 February 2028
|
| View |
|
DRP-8496-01
|
Capecitabine
|
Chymcel
|
500 mg
|
Film-Coated Tablet
|
Antineoplastic (Pyrimidine Analogue)
|
BDR Pharmaceuticals International Pvt. Ltd. (Oncology Unit)
|
India
|
CLIDP Conversion
|
27 September 2024
|
18 October 2029
|
| View |
|
DRP-7742-13
|
Multivitamins + Mineral + Buclizine
|
Hypervit
|
(see formulation on reverse side)
|
Syrup
|
Vitamins/Mineral/Appetite Stimulant
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
15 September 2024
|
05 September 2029
|
| View |
|
DRP-8640-10
|
Azithromycin (as dihydrate)
|
Azro
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Macrolide)
|
Theon Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
15 September 2024
|
22 January 2025
|
| View |
|
DRP-8993-05
|
Gliclazide
|
None
|
30 mg
|
Modified Release Tablet
|
Blood Glucose Lowering Drug (Sulfonylurea)
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
29 September 2024
|
29 July 2025
|
| View |
|
DRP-8832-04
|
Ceftriaxone (as sodium)
|
Ceftrenium
|
1 g
|
Powder for Injection (IM/IV)
|
Antibacterial (Third-Generation Cephalosporin)
|
Injectcare Parenterals Pvt. Ltd.
|
India
|
CLIDP Conversion
|
15 September 2024
|
10 November 2025
|
| View |
|
DRP-8929-17
|
Norepinephrine (as bitartrate)
|
Noren
|
1mg/mL (4 mg/4 mL and 10 mg/10 mL)
|
Solution for Injection (I.V.)
|
Adrenergic/Dopaminergic Agent
|
BCWorld Pharm. Co., Ltd
|
Korea
|
CLIDP Conversion
|
15 September 2024
|
29 July 2025
|
| View |
|
DRP-8677-02
|
Quetiapine (as fumarate)
|
None
|
300 mg
|
Film-Coated Tablet
|
Antipsychotic
|
Sun Pharma Laboratories Limited
|
India
|
CLIDP Conversion
|
29 September 2024
|
30 May 2029
|
| View |
|
DRP-8699-03
|
Oxaliplatin
|
Oxari
|
2 mg / mL (50 mg / 25 mL)
|
Solution for Injection (IV)
|
Antineoplastic
|
Admac Lifesciences
|
India
|
CLIDP Conversion
|
28 September 2024
|
12 September 2028
|
| View |
|
DRP-8640-11
|
Azithromycin (as dihydrate)
|
Zitharix
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Macrolide)
|
Theon Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
24 September 2024
|
22 January 2025
|
| View |
|
DRP-8648-02
|
Cefixime (as trihydrate)
|
Cefipro 200
|
200mg
|
Film-Coated Tablet
|
Antibacterial
|
Celogen Pharma Pvt. Ltd.
|
India
|
CLIDP Conversion
|
27 September 2024
|
26 September 2029
|
| View |
|
DRP-8993-06
|
Gliclazide
|
Retamicron
|
30 mg
|
Modified Release Tablet
|
Blood Glucose Lowering Drug (Sulfonylurea)
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
29 September 2024
|
29 July 2025
|
| View |
|
DRP-9845-02
|
Vancomycin (as hydrochloride)
|
Vancolife
|
500 mg
|
Lyophilized Powder for Injection (I.V.)
|
Antibacterial (Glycopeptide Antibacterial)
|
BCWorld Pharm Co., Ltd.
|
Korea
|
CLIDP Conversion
|
24 September 2024
|
15 July 2026
|
| View |
|
DRP-9837-01
|
Atorvastatin (as calcium)
|
Gostat 20
|
20 mg
|
Film-Coated Tablet
|
HMG-CoA Reductase Inhibitor
|
Umedica Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
24 September 2024
|
23 June 2026
|
| View |
|
DRP-6335-03
|
Calcitriol
|
Rocaldin
|
0.25 mcg
|
Soft Gelatin Capsule
|
Vitamin
|
XL Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
27 September 2024
|
11 September 2030
|
| View |
|
DRP-9838-01
|
Atorvastatin (as calcium)
|
Retastat
|
10 mg
|
Film-Coated Tablet
|
HMG-CoA Reductase Inhibitor
|
Umedica Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
29 September 2024
|
23 June 2026
|
| View |
|
HRP-641-01
|
Methyl Salicylate + Camphor + Menthol
|
Clinica DTX
|
12 g / 12 g / 11 g per 100 mL
|
Liniment
|
Counterirritant
|
A.M. Rieta Corporation
|
Philippines
|
CLIDP Conversion
|
15 September 2024
|
20 December 2028
|
| View |
|
HRP-268-03
|
Isopropyl Alcohol
|
Bodyrite
|
70% (v/v)
|
Solution
|
Antiseptic/Disinfectant
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
15 September 2024
|
29 August 2029
|